Treatment of Ebola virus infection with a recombinant inhibitor of factor VIIa/tissue factor: a study in rhesus monkeys.
about
Animal models for Ebola and Marburg virus infectionsEffective post-exposure treatment of Ebola infectionViral hemorrhagic fevers: advancing the level of treatmentCurrent ebola vaccinesContaining the threat--don't forget EbolaSustained protection against Ebola virus infection following treatment of infected nonhuman primates with ZMAbEmerging targets and novel approaches to Ebola virus prophylaxis and treatmentEbola haemorrhagic feverHelminth infections: the great neglected tropical diseasesGene-specific countermeasures against Ebola virus based on antisense phosphorodiamidate morpholino oligomers.Aberrant coagulation causes a hyper-inflammatory response in severe influenza pneumoniaEbola Hemorrhagic Fever as a Public Health Emergency of International Concern; a Review ArticleFiloviruses: One of These Things is (not) Like the OtherAddressing the Complications of Ebola and Other Viral Hemorrhagic Fever Infections: Using Insights from Bacterial and Fungal SepsisAddressing Therapeutic Options for Ebola Virus Infection in Current and Future OutbreaksPre-symptomatic diagnosis and treatment of filovirus diseasesMouse models for filovirus infectionsProgress in the experimental therapy of severe arenaviral infections[Haemostasis dysregulation in filovirus infections].Neglected filovirusesCirculating microRNA profiles of Ebola virus infectionEbola Viral Disease in West Africa: A Threat to Global Health, Economy and Political StabilityProgress towards the treatment of Ebola haemorrhagic fever.Updates in diagnosis and management of Ebola hemorrhagic fever.Ebola Virus Infection: Review of the Pharmacokinetic and Pharmacodynamic Properties of Drugs Considered for Testing in Human Efficacy Trials.Anti-Ebola therapies based on monoclonal antibodies: current state and challenges ahead.Potential clinical treatment for Ebola pandemic.CHO cell production and sequence improvement in the 13C6FR1 anti-Ebola antibody."Filoviruses": a real pandemic threat?Neutralizing antibody fails to impact the course of Ebola virus infection in monkeysBlood coagulation, inflammation, and malaria.Development and characterization of a mouse model for Marburg hemorrhagic feverPathogenesis and immune response of Crimean-Congo hemorrhagic fever virus in a STAT-1 knockout mouse modelA small nonhuman primate model for filovirus-induced diseasePlatelets and infection - an emerging role of platelets in viral infection.Endothelial cell dysfunction in viral hemorrhage and edema.Thrombocytopenia in Dengue: Interrelationship between Virus and the Imbalance between Coagulation and Fibrinolysis and Inflammatory Mediators.Possible leap ahead in filovirus therapeutics.Post-exposure treatment of non-human primates lethally infected with Ebola virus with EBOTAb, a purified ovine IgG product.Plasmodium falciparum-infected erythrocytes induce tissue factor expression in endothelial cells and support the assembly of multimolecular coagulation complexes
P2860
Q21131118-89405EC9-FABC-4D1F-8E1D-B93C35D690BCQ21131616-7614B01F-FE3F-4870-AA69-E9CB6FC1B241Q21245298-AE599932-B066-492F-9A09-ECC44D4C42BFQ21534720-106D88F5-CD4C-4D3B-B175-11D40CDD2469Q21563447-A2D82A3B-915A-4969-9ECF-7F0850488699Q24594601-3D6964DA-37B8-47A9-B970-A66171A44CB8Q24597625-895BBAE3-D01F-4138-A4F2-DEDE40183B61Q24629338-A76CB907-EBEC-4FC7-926A-23820B461544Q24648324-C905CA29-832B-4602-B7F0-998207997A8AQ25256700-BE349AC8-C8D2-4FB1-AEA4-0C1F7E3D2562Q26753030-C1E29342-F812-43EB-AE6F-48B0B85F98E8Q26778083-1C3104E2-1F97-4E80-B3E1-728DC93EA703Q26783063-8F65F3D4-BD30-433B-AE0B-540C9CA461E8Q26783097-996D28C5-C8C7-4A42-9BE8-C34DF96CD78DQ26801423-41017E69-4F62-4162-9AB0-E6824A124F96Q26823831-DC8782ED-EAC6-4218-8820-E50088997CCDQ27011569-24C3DFAD-EB56-4A7F-8316-99CB597A437AQ27024953-9BE20C88-679E-417D-8D8E-9EDAE50A43D6Q27691452-200D79AC-4278-46CC-9F70-E1C80588354DQ28383265-89A97257-B35C-4B19-8F29-F78192352E68Q28392668-D2CB5F71-098C-47F6-83DC-EB651849DF32Q30148821-52FAEB36-936D-4F1A-A1F4-27F5724E619AQ30230272-60A981E0-3FF2-4F93-A71C-6153D61B235EQ30238537-9AA6213C-3398-48F9-BA53-7DDAA32426C1Q30251949-70D86549-A558-485E-AB85-C8E440C4BCB9Q30252022-1A87654B-6630-4D4E-8B65-6F6A682EF98DQ30366997-ACFDBFBD-6CF9-47ED-B2C8-E7999C4ED5F6Q30383481-797E3E72-F412-448E-BE76-D3B59E436496Q30384090-0F53A86B-E56F-424A-88FF-1506F8FBE14EQ33269796-4EAE0543-06BC-4008-B29A-DA56EC72D695Q33378580-3711AA83-1B41-44AB-91CD-28228968E876Q33384111-3AD6DB8C-FC24-41A5-9F1F-C5C995B59314Q33391592-5C47E99D-2DF1-4E8E-AEED-6BF0C122CEBCQ33397400-2B573994-D413-479C-B64A-D98BDA92C7FCQ33419642-F0D23EA4-AC22-4978-9937-1D9AD5A7791FQ33419868-DCAC47F8-E0C9-4C12-B334-EDC3D0636B84Q33423030-1F1D8B7C-6616-4205-BFBD-C718965AE94EQ33701830-7DEAEC64-1D10-4B73-9C5C-34682820CAA8Q33826350-BC786B38-F635-4010-84A4-2C7C22F511C2Q33941766-D3166486-69F8-4A94-A33E-B90365B8E94E
P2860
Treatment of Ebola virus infection with a recombinant inhibitor of factor VIIa/tissue factor: a study in rhesus monkeys.
description
2003 nî lūn-bûn
@nan
2003 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Treatment of Ebola virus infec ...... or: a study in rhesus monkeys.
@ast
Treatment of Ebola virus infec ...... or: a study in rhesus monkeys.
@en
type
label
Treatment of Ebola virus infec ...... or: a study in rhesus monkeys.
@ast
Treatment of Ebola virus infec ...... or: a study in rhesus monkeys.
@en
prefLabel
Treatment of Ebola virus infec ...... or: a study in rhesus monkeys.
@ast
Treatment of Ebola virus infec ...... or: a study in rhesus monkeys.
@en
P2093
P50
P1433
P1476
Treatment of Ebola virus infec ...... or: a study in rhesus monkeys.
@en
P2093
George P Vlasuk
Howard A Young
Jason Paragas
Joan B Geisbert
Terry M Fredeking
Tom Larsen
William E Rote
P304
P356
10.1016/S0140-6736(03)15012-X
P407
P577
2003-12-01T00:00:00Z